Advanced Analytical Workflow Solutions for Monitoring Critical Quality Attributes of Monoclonal Antibodies

Advanced Analytical Workflow Solutions for Monitoring Critical Quality Attributes of Monoclonal Antibodies

Sponsored Content

Recombinant mAbs tend to be unstable and susceptible to modification/degradation. These mAbs need to be identified/monitored for successful drug development. New advanced LC–MS workflows have been developed to meet such needs.